Literature DB >> 16099412

Aerosolized nanogram quantities of plasmid DNA mediate highly efficient gene delivery to mouse airway epithelium.

Carsten Rudolph1, Ulrike Schillinger, Aurora Ortiz, Christian Plank, Monika M Golas, Bjoern Sander, Holger Stark, Joseph Rosenecker.   

Abstract

The lung is an important target of gene therapeutic interventions. In contrast to intratracheal instillation, inhalation would be the most practical route of administration in clinical applications. Here we show that aerosolized nanogram quantities of pDNA complexed to PEI (350 ng) yielded transfection levels 15-fold higher than a 140-fold higher dose (50 microg) of the same vector applied directly to the lungs of mice via intratracheal intubation. An important efficacy parameter is the osmolarity of the aerosol and not biophysical properties of the nebulized vector. Vectors formulated and nebulized in hypoosmotic distilled water yielded 57- and 185-fold higher expression levels than those in isotonic 5% glucose or Hepes-buffered saline, respectively. Pretreatment of mice with nebulized indomethacin, which prevents water-induced airway alteration, resulted in lower gene expression, whereas pretreatment with EGTA or polidocanol, which modulate tight-junction activity, had no effect. These results, together with histological analysis of regional lung deposition and gene expression, suggest that a temporary water-induced hypoosmotic shock permeabilizes the epithelium sufficiently to allow vector uptake. The so far observed inefficiency of nonviral gene delivery to the airways may be the result of an inappropriate method of vector administration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16099412     DOI: 10.1016/j.ymthe.2005.03.002

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  13 in total

1.  Magnetized aerosols comprising superparamagnetic iron oxide nanoparticles improve targeted drug and gene delivery to the lung.

Authors:  Guenther Hasenpusch; Johannes Geiger; Kai Wagner; Olga Mykhaylyk; Frank Wiekhorst; Lutz Trahms; Alexandra Heidsieck; Bernhard Gleich; Christian Bergemann; Manish K Aneja; Carsten Rudolph
Journal:  Pharm Res       Date:  2012-01-21       Impact factor: 4.200

2.  Modified poly(lactic-co-glycolic acid) nanoparticles for enhanced cellular uptake and gene editing in the lung.

Authors:  Rachel J Fields; Elias Quijano; Nicole Ali McNeer; Christina Caputo; Raman Bahal; Kavi Anandalingam; Marie E Egan; Peter M Glazer; W Mark Saltzman
Journal:  Adv Healthc Mater       Date:  2014-08-25       Impact factor: 9.933

3.  Selective filtering of particles by the extracellular matrix: an electrostatic bandpass.

Authors:  Oliver Lieleg; Regina M Baumgärtel; Andreas R Bausch
Journal:  Biophys J       Date:  2009-09-16       Impact factor: 4.033

4.  Aerosol gene delivery to the murine lung is mouse strain dependent.

Authors:  Petra Dames; Aurora Ortiz; Ulrike Schillinger; Eugenia Lesina; Christian Plank; Joseph Rosenecker; Carsten Rudolph
Journal:  J Mol Med (Berl)       Date:  2006-12-08       Impact factor: 4.599

5.  REV1 is implicated in the development of carcinogen-induced lung cancer.

Authors:  Chad A Dumstorf; Suparna Mukhopadhyay; Elangovan Krishnan; Bodduluri Haribabu; W Glenn McGregor
Journal:  Mol Cancer Res       Date:  2009-01-27       Impact factor: 5.852

Review 6.  Barriers to inhaled gene therapy of obstructive lung diseases: A review.

Authors:  Namho Kim; Gregg A Duncan; Justin Hanes; Jung Soo Suk
Journal:  J Control Release       Date:  2016-05-16       Impact factor: 9.776

7.  Enhanced vaginal drug delivery through the use of hypotonic formulations that induce fluid uptake.

Authors:  Laura M Ensign; Timothy E Hoen; Katharina Maisel; Richard A Cone; Justin S Hanes
Journal:  Biomaterials       Date:  2013-06-13       Impact factor: 12.479

8.  Electroporation- and mechanical ventilation-mediated gene transfer to the lung.

Authors:  C D Kaufman; R C Geiger; D A Dean
Journal:  Gene Ther       Date:  2010-04-29       Impact factor: 5.250

9.  Aerosolized BC-819 inhibits primary but not secondary lung cancer growth.

Authors:  Günther Hasenpusch; Corinna Pfeifer; Manish Kumar Aneja; Kai Wagner; Dietrich Reinhardt; Michal Gilon; Patricia Ohana; Avraham Hochberg; Carsten Rudolph
Journal:  PLoS One       Date:  2011-06-08       Impact factor: 3.240

10.  Polyethylenimine-mediated gene delivery to the lung and therapeutic applications.

Authors:  Sante Di Gioia; Massimo Conese
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.